Pemphigus | |
---|---|
Classification and external resources | |
Specialty | dermatology |
ICD-10 | L10 |
ICD-9-CM | 694.4 |
OMIM |
169600 Benign Chronic ~ 169610 ~ Vulgaris, Familial |
DiseasesDB | 33489 |
MedlinePlus | 000882 |
eMedicine |
derm/317 derm/318 ~ foliaceus derm/314 Drug-induced ~ derm/543 ~ herpetiformis derm/315 ~ IgA derm/319 ~ Vulgaris derm/535 ~Paraneoplastic derm/150 Benign ~ (Hailey-Hailey Disease) |
Patient UK | Pemphigus |
MeSH | D010392 |
Pemphigus (/ˈpɛmfɪɡəs/ or /pɛmˈfaɪɡəs/) is a rare group of blistering autoimmune diseases that affect the skin and mucous membranes. The name is derived from the Greek root "pemphix" meaning "pustule."
In pemphigus, autoantibodies form against desmoglein. Desmoglein forms the "glue" that attaches adjacent epidermal cells via attachment points called desmosomes. When autoantibodies attack desmogleins, the cells become separated from each other and the epidermis becomes "unglued", a phenomenon called acantholysis. This causes blisters that slough off and turn into sores. In some cases, these blisters can cover a significant area of the skin.
Originally, the cause of this disease was unknown, and "pemphigus" was used to refer to any blistering disease of the skin and mucosa. In 1964, researchers found that the blood of patients with pemphigus contained antibodies to the layers of skin that separate to form the blisters. In 1971, an article investigating the autoimmune nature of this disease was published.